NVNO Stock Price, Chart, Stats & News

enVVeno Medical Corporation
Save
160,081
Market cap
–
Current P/E
–
Forward P/E
NVNO chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | – |
ROA | -65.87% |
ROE | -60.88% |
D/E | 0.03x |
Interest coverage ratio | – |
NVNO valuation
P/E | – |
P/S | – |
P/B | 0.23x |
P/CF | -0.40x |
P/FCF | -0.01x |
P/OCF | -0.40x |
PEG | -0.01x |
EV multiple | -0.13x |
About
enVVeno Medical Corporation, based in Irvine, California, is a medical device firm founded in 1999 that is currently in its clinical development phase. The company's primary objective is to pioneer advanced bioprosthetic, tissue-engineered solutions intended to significantly elevate the existing standards of care for patients suffering from venous conditions. Their flagship product is the VenoValve, a specialized replacement venous valve developed for the management of chronic venous insufficiency.
Similar securities
Based on sector and market capitalization
Report issue











